A nondefense-only cap approach may mean estimated cuts of 28% in FY 2024, and near 40% over the next decade, for science agencies like the National Institutes of Health, the National Science Foundation, and NASA.
At the beginning of April, the Congressional Research Service (CRS) released a landmark report outlining the scope of federal investments in regional ecosystems, something we have written about at FAS in the past. This CRS report, ‘Regional Innovation: Federal Programs and Issues for Consideration,’ does an excellent job covering the scope and scale of our massive federal investment […]
Summary By establishing a self-sustaining fund to incentivize pharmaceutical companies to develop new and improved treatment protocols using low-cost, off-patent and unmonopolizable therapies, billions of dollars in cost savings could be realized by US government payers and health insurers in a financially “de-risked” manner while improving quality of care —truly a win/win opportunity. Currently, pharmaceutical companies […]
To address problems of algorithmic harm, the National Institute of Standards and Technology (NIST) should invest in the development of comprehensive AI auditing tools, and federal agencies with the charge of protecting civil rights and liberties should collaborate with NIST to develop these tools and push for comprehensive system audits.
In order to ensure that agency use of AI tools is legal, effective, and equitable, the Biden-Harris Administration should establish a Federal Artificial Intelligence Program to govern the procurement of algorithmic technology.
Development aid can support local businesses, improve outcomes, and cut costs. Here’s how a Supply Chain Commercialization Fund can work with the private sector and build resilient health supply chains in Africa.
Over the past decade, algorithmic decision-making has increasingly impacted the lives of American consumers, and now is the time to ensure lending models offered by private companies are fair and transparent.
Here are industry leaders’ top three takeaways from this year’s Advanced Bioeconomy Leadership Conference.
Economic innovation requires more sophisticated, focused, and better supported local economic planning. Here’s how to achieve it.
The past year has been an exciting time for the bioeconomy as U.S. government agencies work to update their approaches and improve coordination to better support bio-based products and processes.
Operation Warp Speed’s unique success is thanks to strong public-private partnerships, effective coordination, and structured leadership. Here’s how to replicate the OWS model for future success.
This month marks three years since the COVID pandemic took hold of nearly every aspect of American life. In a few more months (May 2023) the coronavirus public health emergency is set to conclude officially, following the Administration’s announcement to wind down the declarations. As the nation grapples with the tragedies and lasting effects of the pandemic, […]